Lawyer Profile Detail
University of Toronto
Steven Tanner is a partner in our Intellectual Property Litigation Group in Toronto.
Mr. Tanner practices exclusively in the areas of Intellectual Property and Litigation, with an emphasis on pharmaceutical patent litigation, oil and gas patent litigation and consumer products patent litigation. He appears frequently in the Federal Court and Federal Court of Appeal, primarily in patent disputes.
A primary focus of Mr. Tanner’s practice relates to pharmaceutical litigation brought pursuant to the PM(NOC) Regulations. A selection of Mr. Tanner’s significant counsel work at hearings on behalf of innovative drug companies includes the following past applications:
- Allergan Inc. et al v. Sandoz Canada Inc. et al (T-154-10) Re: COMBIGAN®
- Allergan Inc. et al v. Apotex Inc. et al (T-1560-10 / A-312-12) Re: COMBIGAN®
- Allergan Inc. et al v. Cobalt Pharmaceuticals Company et al (T-1125-12 / A-321-14) Re: LUMIGAN RC®
- Allergan Inc. et al v. Apotex Inc. et al (T-1151-12 / A-299-14) Re: LUMIGAN RC®
- Allergan Inc. et al v. Sandoz Canada Inc. et al (T-2068-15) Re: LATISSE®
- Allergan Inc. et al v. Apotex Inc. et al (T-1098-15) Re: ALPHAGAN P (0.15%)
- Abbott Laboratories Limited et al v. Apotex Inc. et al (T-585-06) Re: PREVACID®
- Merck & Co. Inc. et al v. Pharmascience Inc. et al (T-1476-08) Re: PROPECIA®
- Schering-Plough Canada Inc. et al v. Pharmascience Inc. et al (T-2102-07) Re: AERIUS®
- Fournier Pharma Inc. et al v. Sandoz Canada Inc. et al (T-1184-10) Re: LIPIDIL EZ®
Mr. Tanner’s practice also focuses on patent infringement actions relating to pharmaceuticals. His significant efforts include AbbVie Corporation and others’ litigation against Janssen Inc. involving the biologic drug STELARA®. His past work for AbbVie Corporation and AbbVie Inc. involves litigation in respect of a treatment for Hepatitis C virus (T-1330-15, T-1332-15 and T-1990-15).
Beyond pharmaceutical litigation, Mr. Tanner has actively represented clients in oil & gas patent infringement cases. He was counsel for Wenzel Downhole Tools at the Federal Court of Appeal and in numerous cases pending before the Federal Court relating to downhole drilling and SAGD processes for the recovery of bitumen including for MEG Energy. Mr. Tanner’s continuing efforts for Aux Sable relate to patented technology on the transportation of natural gas.
Mr. Tanner has also represented clients in patent infringement actions relating to consumer products (as counsel for Costco Wholesale, Wal-Mart Canada and Canadian Tire), Internet Protocol (“IP”) television (as counsel for Bell Canada and TELUS), life sciences (as counsel for Fresh Headies Internet Sales) and machinery (as counsel for Beverly Turf Farms and John Vanderwoude Sod Farms).
Mr. Tanner received his Honours Co-operative Biochemistry (Biotechnology option) BSc from the University of Waterloo in 2001, and his JD from the University of Toronto Law School in 2005. He was called to the Ontario bar in 2006.
Mr. Tanner is a member of the Intellectual Property Institute of Canada (IPIC), the Law Society of Upper Canada (LSUC), the Ontario Bar Association (OBA) and the Canadian Bar Association (CBA).
Mr. Tanner was an integral member of the team that won Managing IP's Patent Contentious Team of the Year - Canada for three consecutive years (2013-2015). Mr. Tanner was also a key member of the team that won Managing IP's Milestone Case of the Year - Canada in 2015.
In his spare time, Mr. Tanner is an avid guitar player. His band has released two albums and has performed at the El Mocambo and elsewhere in southern Ontario. He is also a dedicated downhill skier who has challenged the slopes in BC, Alberta, Quebec, Colorado, Wyoming, Vermont, New York, Arizona, New Mexico and Utah. Mr. Tanner is an active member of Triathlon Ontario and the Toronto Triathlon Club and has competed in numerous triathlons at the sprint, Olympic and IRONMAN 70.3 distances.
Canada's Federal Court of Appeal Upholds C$180 Million Judgment in Favour of Merck Against Apotex in a Landmark Patent Damages Ruling
Pfizer Liable to Apotex for Section 8 Damages: Amount to Be Determined
With "One-Click," Business Methods Are Patentable in Canada
Dedication to the Public: An Important Tool for Innovators
Federal Court Clarifies Duty of Candour Owed During Prosecution of Patent Applications
Patentees Score a Victory in the Supreme Court of Canada:
Validity of Selection Patents Upheld
Proposed Canadian Copyright Reform — Bill C-61
The Fallout of AstraZeneca Canada Inc. v. Canada (Minister of Health) (2)
The Fallout of AstraZeneca Canada Inc. v. Canada (Minister of Health) (1)
SCC Re-examines the NOC Regulations in AstraZeneca Canada Inc. v. Canada (Minister of Health)